Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.

Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL.

Schizophr Res. 2008 Dec;106(2-3):268-74. doi: 10.1016/j.schres.2008.07.017.

2.

Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.

Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB.

Schizophr Res. 2011 May;128(1-3):61-5. doi: 10.1016/j.schres.2011.01.020.

PMID:
21353483
3.

Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.

Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH.

Arch Gen Psychiatry. 2003 May;60(5):466-72.

PMID:
12742867
4.

Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.

Prasad KM, Eack SM, Goradia D, Pancholi KM, Keshavan MS, Yolken RH, Nimgaonkar VL.

Am J Psychiatry. 2011 Aug;168(8):822-30. doi: 10.1176/appi.ajp.2011.10101423.

5.

Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A.

Ethiop Med J. 2011 Jul;49(3):211-20.

PMID:
21991754
6.

Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis.

Blomström Å, Gardner RM, Dalman C, Yolken RH, Karlsson H.

Transl Psychiatry. 2015 Feb 3;5:e502. doi: 10.1038/tp.2014.142.

7.

Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1137-48. doi: 10.1093/schbul/sbs046. Review.

8.

Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia?

Kim JJ, Shirts BH, Dayal M, Bacanu SA, Wood J, Xie W, Zhang X, Chowdari KV, Yolken R, Devlin B, Nimgaonkar VL.

Ann Med. 2007;39(2):145-53.

PMID:
17453677
9.

Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms.

Bolu A, Oznur T, Tok D, Balikci A, Sener K, Celik C, Gulsun M.

Psychiatr Danub. 2016 Jun;28(2):132-8.

10.

Persistent infection with neurotropic herpes viruses and cognitive impairment.

Watson AM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, Bradford LD, Calkins ME, Richard J, Edwards N, Savage RM, Allen TB, Kwentus J, McEvoy JP, Santos AB, Wiener HW, Go RC, Perry RT, Nasrallah HA, Gur RE, Devlin B, Nimgaonkar VL.

Psychol Med. 2013 May;43(5):1023-31. doi: 10.1017/S003329171200195X.

PMID:
22975221
11.

Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R.

Schizophr Res. 2012 Jan;134(1):83-8. doi: 10.1016/j.schres.2011.10.003.

PMID:
22048011
12.

Antibodies to infectious agents in individuals with recent onset schizophrenia.

Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH.

Eur Arch Psychiatry Clin Neurosci. 2004 Feb;254(1):4-8.

PMID:
14991372
13.

Deficit schizophrenia: association with serum antibodies to cytomegalovirus.

Dickerson F, Kirkpatrick B, Boronow J, Stallings C, Origoni A, Yolken R.

Schizophr Bull. 2006 Apr;32(2):396-400.

14.

Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study.

Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL.

J Med Virol. 1994 Jan;42(1):33-7.

PMID:
8308517
15.

Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia.

Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL.

Mol Psychiatry. 2007 Jan;12(1):105-13, 1.

PMID:
17033628
16.

Antibodies to infectious agents in individuals at ultra-high risk for psychosis.

Amminger GP, McGorry PD, Berger GE, Wade D, Yung AR, Phillips LJ, Harrigan SM, Francey SM, Yolken RH.

Biol Psychiatry. 2007 May 15;61(10):1215-7.

PMID:
17207471
17.

Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.

Zhou Y, Bian G, Zhou Q, Gao Z, Liao P, Liu Y, He M.

J Med Virol. 2015 Oct;87(10):1749-53. doi: 10.1002/jmv.24218.

PMID:
25976377
18.

Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study.

Jonker I, Klein HC, Duivis HE, Yolken RH, Rosmalen JG, Schoevers RA.

PLoS One. 2014 Jul 1;9(7):e101549. doi: 10.1371/journal.pone.0101549.

19.

[Prevalence of antibodies against Toxoplasma gondii, rubella virus, cytomegalovirus and herpes simplex virus in pregnant women of Catalonia].

Pumarola A, Salleras L, Vidal J, Canela J, Mas J, Jiménez de Anta MT, Pumarola T, Coll JJ, de la Puente ML.

Enferm Infecc Microbiol Clin. 1989 Feb;7(2):83-6. Spanish.

PMID:
2562317
20.

Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring--a matched case-control study.

Blomström A, Karlsson H, Wicks S, Yang S, Yolken RH, Dalman C.

Schizophr Res. 2012 Sep;140(1-3):25-30. doi: 10.1016/j.schres.2012.06.035.

PMID:
22819777
Items per page

Supplemental Content

Support Center